If you’ve ever wondered how biotech truly gets funded and commercialized… this one is for you!
HYGEIA Co-Founder & Managing Partner (Amin Jagani) discusses Biotech investing in the latest episode of Beyond Max Q Podcast with host, Mollie Jahner. Amin Jagani, co-founder of The HYGEIA Group, spent 25+ years navigating biotech, pharma, and precision oncology.
In this episode, Amin discusses:
• What investors actually look for in early-stage biotech
• Why commercialization takes years (and billions)
• The partnerships required to survive long development cycles
• How AI is reshaping drug development and biotech careers
• The resilience founders must build in a high-risk industry
If you’re building in biotech—or supporting those who are—this conversation is full of hard-earned lessons and real-world strategy.
Watch the full interview here.